Benitec Biopharma Limited EV/FCF

EV/FCF of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart. A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.


Highlights and Quick Summary

Current EV/FCF of Benitec Biopharma Limited is 0.21 (as of June 30, 2022)
  • EV/FCF for the quarter ending June 30, 2022 was 0.21 (a -56.65% decrease compared to previous quarter)
  • Year-over-year quarterly EV/FCF decreased by -85.87%
  • Annual EV/FCF for 2022 was 0.21 (a -85.87% decrease from previous year)
  • Annual EV/FCF for 2021 was 1.46 (a 7.48% increase from previous year)
  • Annual EV/FCF for 2021 was 1.36 (a 10.63% increase from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/FCF of Benitec Biopharma Limited

Most recent EV/FCFof BNTC including historical data for past 10 years.

Interactive Chart of EV/FCF of Benitec Biopharma Limited

Benitec Biopharma Limited EV/FCF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.21 0.48 0.21
2021 0.75 1.46 1.01 1.46
2020 1.36 0.73 1.23 1.67 1.23
2019 1.42 1.52 0.5
2018 -0.64
2017 -0.74 -0.18
2016 -0.01 0.57
2015 0.75
2014 0.0
2013 0.0

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology